A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine
Clinical trial NCT04522089 · COMPLETED
Trial details
- NCT number
- NCT04522089
- Sponsor
- Adimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-24
- Primary completion
- 2020-11-20
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.